IBD SCOPE - IBD scope
8
home,page-template,page-template-full_width,page-template-full_width-php,page,page-id-8,theme-bridge,bridge-core-2.1.1,cookies-not-set,woocommerce-no-js,ajax_fade,page_not_loaded,,qode-title-hidden,columns-3,qode-product-single-tabs-on-bottom,qode-child-theme-ver-1.0.0,qode-theme-ver-24.1,qode-theme-bridge,disabled_footer_top,wpb-js-composer js-comp-ver-6.1,vc_responsive

Welcome to

Our platform offers the latest medical news and expert perspectives in IBD;
essential point-of-care drug and disease information;
and relevant professional education.

OUR MISSION

Our mission is to improve medical education with clinical information
and resources essential to physicians
and healthcare professionals.

Who we are

Supporter

Supporter: Janssen Immunology

NEXT APPOINTMENTS

FEBRUARY 8th, 2021
IBDscope
Mucosal healing in ulcerative colitis

MARCH 1st, 2021
IBDforum
Early disease control

MARCH 8th, 2021
IBDscope
Transmural healing in CD: the ultimate therapeutic goal

APRIL 12th, 2021
IBDscope
EIM in IBD: looking beyond anti-TNF

MAY 3rd, 2021
IBDscope
Positioning drugs in clinical practice: matter of choice

JUNE 14th, 2021
IBDscope
BEST OF DDW: From clinical data to clinical practice

JULY 23rd, 2021
IBDscope
BEST OF ECCO 2021

WEBINARS ON DEMAND

JANUARY 11th, 2021
IBDforum
JAK selectivity or GUT selectivity for IBD treatment

NOVEMBER 6nd, 2020
h. 4:00 pm CET
Best of UEG Week Virtual 2020

NOVEMBER 2nd, 2020
h. 2:00 PM CET
Stardust from trial to practice

OCTOBER 27th, 2020
h. 5:00 PM CEST
JAKademy – HOW JAK/STAT INHIBITION TRANSLATES IN CLINICS?

OCTOBER 8th, 2020
h. 1:30-3:00 PM CEST
OPTIMISE MILD-MODERATE UC ACADEMY

OCTOBER 5th, 2020
h. 2:00 PM CEST
A new look at treat to target strategies in Crohn’s disease

OCTOBER 1st, 2020
h. 1:30-3:00 PM CEST
OPTIMISE MILD-MODERATE UC ACADEMY

SEPTEMBER 28th, 2020
h. 1:30-3:00 PM CEST
OPTIMISE MILD-MODERATE UC ACADEMY

SEPTEMBER, 19th 2020
IBDscope
INFLIXIMAB TREATMENT IN IBD – FROM THEORY TO CLINICAL PRACTICE

SEPTEMBER, 15th 2020
IBDscope
JAKademy – ADDRESSING UNMET NEEDS IN IBD WITH JAK INHIBITION

SEPTEMBER, 7th 2020
IBDforum
GLOBAL IBD FORUM – Disease clearance in UC why and how

JULY, 21st 2020
IBD Practice – on Air
Janssen Virtual Symposium – Dynamic management advancing the management of IBD

JULY, 16 2020
IBD scope
Early intervention in ulcerative colitis: Ready for prime time?

JULY, 9 2020
IBD Virtual Preceptorship

JULY, 8 2020
IBD Virtual Preceptorship

JULY, 7 2020
IBD Practice – on Air
Celltrion Virtual symposium – Beyond current treatment options in IBD Subcutaneous infliximab

JUNE, 16 2020
IBD Practice – on Air
Gilead Galapagos Virtual symposium – Evolving treatment in Ulcerative Colitis

JUNE, 2 2020
IBD Practice – on Air
AbbVIe Symposium – Weighing the Balance of Steroid Use in IBD – Friend and Foe

MAY, 28 2020
THE DAY AFTER COVID-19 FOR IBD MANAGEMENT: How to get back to “almost” normality

MAY, 25 2020
BEST OF DDW: FROM CLINICAL DATA TO CLINICAL PRACTICE

MAY, 13 2020
COVID-19 and IBD MANAGEMENT

MAY, 8 2020
IBD MANAGEMENT during COVID-19 outbreak Update

APRIL, 30 2020
IBD MANAGEMENT during COVID-19 outbreak Update

APRIL, 28 2020
THE DAY AFTER COVID-19 NELLE IBD

APRIL, 28 2020
WEBINAR IBD CARE AND COVID-19 – JAPAN

APRIL, 27 2020
IBD and COVID-19: the invisible enemy

APRIL, 21 2020
New Insights for COVID-19 and IBD management

APRIL, 16th 2020
PM session h.5:00 PM CEST
IBD AND RHEUMATIC DISEASE TREATMENT AT TIME OF COVID-19 PANDEMIC

APRIL, 8 2020
AM session h11:00 CEST
PM session h17:00 CEST
WHAT IBD SPECIALIST NEEDS TO KNOW ABOUT COVID-19 PANDEMIC

APRIL, 1 2020
Gestione delle mici durante il covid-19

MARCH, 31 2020
AM session h10:00 CEST
PM session h16:00 CEST
IBD management during COVID-19 outbreak